Engineers Gate Manager’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-1,558
| Closed | -$286K | – | 2251 |
|
|
2026
Q1 | $286K | Buy |
+1,558
| New | +$287K | ﹤0.01% | 1728 |
|
|
2025
Q3 | – | Sell |
-33,008
| Closed | -$4.15M | – | 2175 |
|
|
2025
Q2 | $4.15M | Sell |
33,008
-43,950
| -57% | -$5.48M | 0.05% | 448 |
|
|
2025
Q1 | $10.5M | Buy |
76,958
+48,915
| +174% | +$6.99M | 0.18% | 130 |
|
|
2024
Q4 | $4.29M | Buy |
28,043
+10,051
| +56% | +$1.7M | 0.07% | 346 |
|
|
2024
Q3 | $3.49M | Buy |
+17,992
| New | +$3.76M | 0.07% | 394 |
|
|
2024
Q2 | – | Sell |
-39,840
| Closed | -$8.59M | – | 1927 |
|
|
2024
Q1 | $8.59M | Buy |
+39,840
| New | +$9.33M | 0.23% | 98 |
|
|
2023
Q2 | – | Sell |
-3,462
| Closed | -$963K | – | 1739 |
|
|
2023
Q1 | $963K | Sell |
3,462
-2,834
| -45% | -$784K | 0.04% | 668 |
|
|
2022
Q4 | $1.74M | Buy |
6,296
+3,647
| +138% | +$1.03M | 0.1% | 232 |
|
|
2022
Q3 | $707K | Sell |
2,649
-10,982
| -81% | -$2.33M | 0.04% | 601 |
|
|
2022
Q2 | $2.78M | Buy |
13,631
+2,295
| +20% | +$469K | 0.1% | 253 |
|
|
2022
Q1 | $2.39M | Buy |
11,336
+10,095
| +813% | +$2.2M | 0.09% | 264 |
|
|
2021
Q4 | $298K | Sell |
1,241
-1,474
| -54% | -$379K | 0.01% | 1414 |
|
|
2021
Q3 | $768K | Buy |
2,715
+55
| +2% | +$18K | 0.04% | 632 |
|
|
2021
Q2 | $921K | Buy |
+2,660
| New | +$806K | 0.06% | 472 |
|
|
2021
Q1 | – | Sell |
-12,908
| Closed | -$3.16M | – | 1815 |
|
|
2020
Q4 | $3.16M | Buy |
12,908
+11,011
| +580% | +$2.84M | 0.14% | 179 |
|
|
2020
Q3 | $538K | Sell |
1,897
-7,041
| -79% | -$1.96M | 0.03% | 958 |
|
|
2020
Q2 | $2.39M | Buy |
8,938
+7,908
| +768% | +$2.38M | 0.12% | 210 |
|
|
2020
Q1 | $326K | Sell |
1,030
-15,174
| -94% | -$4.6M | 0.02% | 984 |
|
|
2019
Q4 | $4.81M | Buy |
16,204
+3,608
| +29% | +$1M | 0.21% | 95 |
|
|
2019
Q3 | $2.93M | Buy |
+12,596
| New | +$2.93M | 0.15% | 202 |
|
|
2019
Q2 | – | Sell |
-10,300
| Closed | -$2.44M | – | 1139 |
|
|
2019
Q1 | $2.44M | Buy |
+10,300
| New | +$3.24M | 0.15% | 210 |
|
|
2017
Q2 | – | Sell |
-5,300
| Closed | -$1.45M | – | 639 |
|
|
2017
Q1 | $1.45M | Buy |
+5,300
| New | +$1.5M | 0.14% | 267 |
|
|
2015
Q2 | – | Sell |
-1,759
| Closed | -$743K | – | 1017 |
|
|
2015
Q1 | $743K | Buy |
1,759
+1,124
| +177% | +$443K | 0.1% | 386 |
|
|
2014
Q4 | $216K | Buy |
+635
| New | +$205K | 0.06% | 574 |
|
Other funds holding BIIB
Engineers Gate Manager's BIIB Position: Q2 2026 in Review
Engineers Gate Manager sold out of Biogen (BIIB) in Q2 2026, closing a stake of 1,558 shares — an estimated $286K sold.
Engineers Gate Manager first reported a position in BIIB in Q4 2014 and held it in 24 quarters. The position peaked at $10.5M in Q1 2025. 1,036 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- Engineers Gate Manager reported no remaining Biogen position as of Q2 2026 after selling out during the quarter.
- Engineers Gate Manager sold 1,558 Biogen shares in Q2 2026, an estimated $286K.
- Engineers Gate Manager first reported a position in Biogen in Q4 2014 and held it in 24 quarters.
- Engineers Gate Manager's Biogen position peaked at $10.5M in Q1 2025.
- 1,036 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.